Do Traders Think Ovid Therapeutics Inc (OVID) Can Keep Climbing Friday?

Ovid Therapeutics Inc (OVID) stock is up 10.34% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Ovid Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on OVID!

See Full OVID Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With OVID Stock Today?

Ovid Therapeutics Inc (OVID) stock has gained 2.81% while the S&P 500 is down -0.57% as of 9:59 AM on Friday, Sep 15. OVID has gained $0.11 from the previous closing price of $3.84 on volume of 54,316 shares. Over the past year the S&P 500 is up 13.52% while OVID has gained 83.72%. OVID lost -$0.70 per share in the over the last 12 months. To screen for more stocks like Ovid Therapeutics Inc click here.

More About Ovid Therapeutics Inc

Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life. Click Here to get the full Stock Report for Ovid Therapeutics Inc stock.